NVS Depreciation & Amortization
Novartis AG Common Stock · Depreciation & Amortization
NVS Depreciation & Amortization
Latest reported$5.34Bperiod ending
NVS Depreciation & Amortization ($1.01B → $5.34B)
Annual Depreciation & Amortization
High-resolution chart · PNG
NVS depreciation & amortization history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 5,352,269,000 | |
| 6,069,000,000 | |
| 8,277,000,000 | |
| 6,705,000,000 | |
| 5,597,000,000 | |
| 6,464,000,000 | |
| 5,826,000,000 | |
| 5,211,000,000 | |
| 4,736,000,000 | |
| 6,043,000,000 | |
| 5,471,000,000 | |
| 4,682,000,000 | |
| 4,405,000,000 | |
| 4,442,000,000 | |
| 5,788,000,000 | |
| 3,419,000,000 | |
| 2,301,000,000 | |
| 2,670,000,000 | |
| 2,858,000,000 | |
| 1,923,000,000 | |
| 1,621,000,000 | |
| 1,299,000,000 | |
| 1,283,000,000 | |
| 1,295,000,000 | |
| 1,037,000,000 | |
| 741,000,000 | |
| 948,000,000 | |
| 1,008,720,930 |